230 related articles for article (PubMed ID: 23073318)
21. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
Paccou J; Viget N; Drumez E; Cortet B; Robineau O
Med Mal Infect; 2018 Oct; 48(7):442-448. PubMed ID: 29699830
[TBL] [Abstract][Full Text] [Related]
22. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
Fernández-Rivera J; García R; Lozano F; Macías J; García-García JA; Mira JA; Corzo JE; Gómez-Mateos J; Rueda A; Sánchez-Burson J; Pineda JA
HIV Clin Trials; 2003; 4(5):337-46. PubMed ID: 14583850
[TBL] [Abstract][Full Text] [Related]
23. Characterization of osteopenia/osteoporosis in adult scoliosis: does bone density affect surgical outcome?
Yagi M; King AB; Boachie-Adjei O
Spine (Phila Pa 1976); 2011 Sep; 36(20):1652-7. PubMed ID: 21304426
[TBL] [Abstract][Full Text] [Related]
24. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
Patel R; Blake GM; Fogelman I
Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990
[TBL] [Abstract][Full Text] [Related]
25. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
[TBL] [Abstract][Full Text] [Related]
26. Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors.
Chisati EM; Constantinou D; Lampiao F
PLoS One; 2020; 15(1):e0227893. PubMed ID: 31935270
[TBL] [Abstract][Full Text] [Related]
27. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
Carr A; Miller J; Eisman JA; Cooper DA
AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
Aydın OA; Karaosmanoglu HK; Karahasanoglu R; Tahmaz M; Nazlıcan O
Braz J Infect Dis; 2013; 17(6):707-11. PubMed ID: 24076108
[TBL] [Abstract][Full Text] [Related]
29. Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.
Beerhorst K; Tan IY; De Krom M; Verschuure P; Aldenkamp AP
Acta Neurol Scand; 2013 Oct; 128(4):273-80. PubMed ID: 23461582
[TBL] [Abstract][Full Text] [Related]
30. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
[TBL] [Abstract][Full Text] [Related]
31. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
[TBL] [Abstract][Full Text] [Related]
32. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
33. Low bone mass in human immunodeficiency virus-infected climacteric women receiving antiretroviral therapy: prevalence and associated factors.
Gomes DC; Valadares AL; de Moraes MJ; Lagrutta BB; Pinto-Neto AM; Costa-Paiva L
Menopause; 2015 Feb; 22(2):224-30. PubMed ID: 25003619
[TBL] [Abstract][Full Text] [Related]
34. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
35. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
Rehman Q; Lang T; Modin G; Lane NE
Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
[TBL] [Abstract][Full Text] [Related]
36. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
[TBL] [Abstract][Full Text] [Related]
37. Body composition in HIV-infected patients receiving highly active antiretroviral therapy.
Chițu-Tișu CE; Barbu EC; Lazăr M; Bojincă M; Tudor AM; Hristea A; Abagiu AO; Ion DA; Bădărău AI
Acta Clin Belg; 2017 Feb; 72(1):55-62. PubMed ID: 27724840
[TBL] [Abstract][Full Text] [Related]
38. Bone mineral density of vegetarian and non-vegetarian adults in Taiwan.
Wang YF; Chiu JS; Chuang MH; Chiu JE; Lin CL
Asia Pac J Clin Nutr; 2008; 17(1):101-6. PubMed ID: 18364334
[TBL] [Abstract][Full Text] [Related]
39. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
[TBL] [Abstract][Full Text] [Related]
40. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]